312 related articles for article (PubMed ID: 14675858)
1. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Müller K; Gamba G; Jaquet F; Hess B
Eur J Heart Fail; 2003 Dec; 5(6):793-801. PubMed ID: 14675858
[TBL] [Abstract][Full Text] [Related]
2. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
3. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
4. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Chetboul V; Pouchelon JL; Menard J; Blanc J; Desquilbet L; Petit A; Rougier S; Lucats L; Woehrle F;
J Vet Intern Med; 2017 Nov; 31(6):1629-1642. PubMed ID: 28975664
[TBL] [Abstract][Full Text] [Related]
6. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
Noe LL; Vreeland MG; Pezzella SM; Trotter JP
Clin Ther; 1999 May; 21(5):854-66. PubMed ID: 10397380
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
TORAFIC Investigators Group
Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
[TBL] [Abstract][Full Text] [Related]
8. Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(6):679-703. PubMed ID: 11456215
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
[TBL] [Abstract][Full Text] [Related]
10. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
[TBL] [Abstract][Full Text] [Related]
11. Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Spannheimer A; Goertz A; Dreckmann-Behrendt B
Int J Clin Pract; 1998 Oct; 52(7):467-71. PubMed ID: 10622087
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Stroupe KT; Forthofer MM; Brater DC; Murray MD
Pharmacoeconomics; 2000 May; 17(5):429-40. PubMed ID: 10977385
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Besche B; Blondel T; Guillot E; Garelli-Paar C; Oyama MA
J Vet Intern Med; 2020 Sep; 34(5):1746-1758. PubMed ID: 32767627
[TBL] [Abstract][Full Text] [Related]
14. [Update: prolonged-release torasemide].
Acuña C
Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
[TBL] [Abstract][Full Text] [Related]
15. [Effects of various diuretics on cardiac function in rats with heart failure].
Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Balsam P; Ozierański K; Marchel M; Gawałko M; Niedziela Ł; Tymińska A; Sieradzki B; Sieradzki M; Fojt A; Bakuła E; Główczyńska R; Peller M; Markulis M; Bednarski J; Kowalik R; Cacko A; Niewiński G; Filipiak KJ; Opolski G; Grabowski M
Cardiol J; 2019; 26(6):661-668. PubMed ID: 31909470
[TBL] [Abstract][Full Text] [Related]
17. Torasemide for the treatment of heart failure.
Ishido H; Senzaki H
Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
[TBL] [Abstract][Full Text] [Related]
18. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
Murray MD; Deer MM; Ferguson JA; Dexter PR; Bennett SJ; Perkins SM; Smith FE; Lane KA; Adams LD; Tierney WM; Brater DC
Am J Med; 2001 Nov; 111(7):513-20. PubMed ID: 11705426
[TBL] [Abstract][Full Text] [Related]
19. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
[TBL] [Abstract][Full Text] [Related]
20. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
